This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roy-Chaudhury, P. Search for Related Content PubMed PubMed Citation Articles by Roy-Chaudhury, P. Related Collections Restenosis Smooth muscle proliferation and differentiation Endothelium/vascular type/nitric oxide Other Vascular biology Related Article

(Circulation. 2005;112:3-5.)
© 2005 American Heart Association, Inc.

Editorial

Endothelial Progenitor Cells, Neointimal Hyperplasia, and Hemodialysis Vascular Access Dysfunction

Novel Therapies for a Recalcitrant Clinical Problem

Prabir Roy-Chaudhury, MD, PhD

From the University of Cincinnati Medical Center, Cincinnati, Ohio.

Correspondence to Dr Prabir Roy-Chaudhury, Division of Nephrology, MSB G-258, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0585. E-mail prabir.roychaudhury@uc.edu

Key Words: Editorials • stenosis • grafting • hyperplasia • endothelium

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Vascular stenosis as a result of neointimal hyperplasia is a major clinical problem that has an impact on multiple and diverse disciplines, including cardiology (coronary restenosis), cardiothoracic and vascular surgery (saphenous vein and polytetrafluoroethylene [PTFE] graft failure), neurology (carotid stenosis), nephrology (dialysis access dysfunction), and transplant medicine (chronic allograft rejection in hearts and kidneys). The traditional response to injury hypothesis on the pathogenesis of neointimal hyperplasia focuses on the migration of medial smooth muscle cells from the media into the intima.¹ Recently, there has been a great deal of excitement about the role of circulating smooth muscle progenitor cells in the pathogenesis of neointimal hyperplasia. These cells have been identified in a variety of experimental models of vascular injury,² and interventions that reduce the number of these cells can attenuate neointimal hyperplasia. In marked contrast to the deleterious effects of smooth muscle progenitor cells on neointimal hyperplasia, circulating endothelial progenitor cells (EPCs) are believed to play an important role in vascular repair and in the inhibition of neointimal hyperplasia.³

See p 12

In this issue of Circulation, Rotmans and colleagues have attempted to achieve the "holy grail" for a vascular access procedure: rapid and complete endothelialization.⁴ Their experiments are based on a newly developed technique that can coat the surface of stent and graft material with antibodies against CD34 (Orbus Medical Technologies). CD34 is a marker for hematopoietic stem cells, and previous research has demonstrated that coronary stents coated with anti-CD34 have a significant increase in endothelialization as early . . . [Full Text of this Article]

Related Article:

In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts

Joris I. Rotmans, Jan M.M. Heyligers, Hence J.M. Verhagen, Evelyn Velema, Machiel M. Nagtegaal, Dominique P.V. de Kleijn, Flip G. de Groot, Erik S.G. Stroes, and Gerard Pasterkamp
Circulation 2005 112: 12-18. [Abstract] [Full Text]

This article has been cited by other articles:

				M. J. Kern Persistent endothelial dysfunction after drug-eluting stents another continuing cost of reducing restenosis. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 72 - 73. [Full Text] [PDF]

				N. M. Caplice, S. Wang, M. Tracz, A. J. Croatt, J. P. Grande, Z. S. Katusic, and K. A. Nath Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat Am J Physiol Renal Physiol, August 1, 2007; 293(2): F470 - F475. [Abstract] [Full Text] [PDF]

				B. Doyle, N. Caplice, J. I. Rotmans, J. M.M. Heyligers, H. J.M. Verhagen, E. Velema, D. P.V. de Kleijn, G. Pasterkamp, M. M. Nagtegaal, E. S.G. Stroes, et al. Letter Regarding Article by Rotmans et al, "In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts" * Response Circulation, December 13, 2005; 112(24): e359 - e360. [Full Text] [PDF]